Post-approval studies (Phase 4)Study completedNCT02175186
What this trial is testing
Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Who this might be right for
GastritisGastroduodenal Ulcer
Young-Hak Kim, MD, PhD 47